[1]
A. N. V., A. JOHN, S. P. R., S. PRIYA, C. RAVIRAJ, and . H. ASHTEKAR, “OPTIMIZED SOLID LIPID NANOPARTICLES FOR ENHANCED ORAL BIOAVAILABILITY AND OSTEOGENIC EFFECT OF IPRIFLAVONE: FORMULATION, CHARACTERIZATION, AND IN VITRO EVALUATION”, Int J App Pharm, vol. 16, no. 6, pp. 79–89, Nov. 2024.